A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
Clinical trial NCT05085418 · UNKNOWN
Trial details
- NCT number
- NCT05085418
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-11-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.